Even Big Pharma's country managers don't know true cost of drugs, only transfer prices - and anomalies aboundhttps://twitter.com/MichaelWestBiz/status/610248698627424256 …
@alexcobham - If it’s a problem that they only know transfer prices, wld it be better if they operated with two sets of books? Seems no win
-
-
@MForstater Ah, ok. Seems little question there are 2 sets of books, no? Secrecy of TPs leaves country managers maximising profit blind. -
@alexcobham I dunno. What to base upstream P&L on? Costs of prodn? R&D but only of the drugs that sell? R&D for drugs that didn’t make it? - 11 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.